EUS-guided Ablation of Pancreatic Cyst Neoplasms

Description

This is a registry that will maintain prospective data on the clinical outcomes of all patients with pancreatic cyst lesions who undergo EUS-guided alcohol ablation.

Conditions

Pancreatic Cyst

Talk to us

Study Overview

On this page

Study Details

Study overview

This is a registry that will maintain prospective data on the clinical outcomes of all patients with pancreatic cyst lesions who undergo EUS-guided alcohol ablation.

Endoscopic Ultrasound (EUS)-Guided Ablation of Pancreatic Cyst Neoplasms

EUS-guided Ablation of Pancreatic Cyst Neoplasms

Condition
Pancreatic Cyst
Intervention / Treatment

-

Contacts and Locations

Orlando

AdventHealth, Orlando, Florida, United States, 32803

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Benign branch-duct intraductal papillary mucinous neoplasm (IPMN) or mucinous cyst neoplasm (MCN) measuring \>2 and up to 4cm in size and located in the head or body of the pancreas.
  • 2. Benign branch-duct IPMN or MCN measuring \> 2 and up to 4cm in size and located in the tail of the pancreas in a high-risk surgical candidate.
  • 3. A branch-duct IPMN or MCN with high-risk features (mural nodule or enlarging in size) in a high-risk surgical patient.
  • 4. Indeterminate cyst lesions
  • 1. Cysts measuring \<2cm or \>4cm.
  • 2. Multiloculated cysts (\>4 locules).
  • 3. Cysts with vascular supply.
  • 4. Cysts communicating with the main pancreatic duct via an obvious side-branch measuring 2mm or more in diameter.
  • 5. Cysts with hypoechoic mass lesions that on fine needle aspiration (FNA)reveal malignant cells.
  • 6. Recent history of pancreatitis and EUS findings suggestive of a pseudocyst.
  • 7. Bleeding tendency; international normalized ratio (INR) \>1.4 or platelet count \<70,000.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

AdventHealth,

Muhammad Hasan, MD, PRINCIPAL_INVESTIGATOR, AdventHealth

Study Record Dates

2025-12-01